StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 
 
 
Ascendis Pharma A/S
157.54
-1.17%
 

ASND

 

Ascendis Pharma A/S Ameri

$ 157.54

 
-$1.86 | -1.17%
 
 
Open
$ 158.20
 
 
MKT CAP
$ 9.09B
 
High
$ 161.00
 
 
VOL
$ 310.04K
 
Low
$ 156.79
 
 
AVG VOL
$ 0.47M
 
 
 

ASND Stock Analysis

Ascendis Pharma A/S Ameri (ASND) still has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

ASND Total Score

 

Chart

 
 

131.23

91.41

93.57

113.35

 
 
1month
3month
6month
1year
 
Total Return
ASND
vs.
S&P500
 

 
1-week Return
+0.50%
 
+1.89%
 
 
5-week Return
+19.33%
 
+4.75%
 
 
10-week Return
+42.97%
 
+9.17%
 
 
 
 

Strengths

ASND Rewards

 Earnings are forecast to grow

 
 

ASND Risk Level

This Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
ASND Risk Level
LOW
HIGH

Risk Volatility

 

ASND has Low Risk Level

Click here to check what is your level of risk

 

ASND Analysts Opinion

The company overall standing based on key factors, offering insights into analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.00
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.00
 

ASND Future Sentiment

 Earnings are forecast to grow

 
 

ASND Analysts Opinion

ASND Analysts opinion is negative and it remained unchanged from the past 3 months

 

ASND Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
0%
100%
 
On Track
On Track
On Track
 

ASND Street Opinion 

ASND Street view is extremely ish and have positive views on the near-term outlook

 

ASND Performance Sentiment

Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
100%
0%
Positive
Negative
8 out of 8
events present
0 out of 8
events present
 
 
Highlights
Last Modify
Price
% Change

 
Investors Activity
2 Weeks Ago
139.29
-1.10%
 
New Product
2 Weeks Ago
143.14
+2.41%
 
New Product
3 Weeks Ago
129.93
+0.57%
 
Agreements
2 Month Ago
138.24
+6.57%
 
Investors Activity
2 Month Ago
127.36
+0.20%
 
 

ASND Latest News Feed








 
 
 
joker
 
 
 
StocksRunner

Explore our ASND Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ASND Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

ASND Rewards

 Earnings are forecast to grow

 
 
 

ASND Risk Level

 
 
 

The Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
ASND Risk Level
LOW
HIGH

Risk Volatility

 

ASND has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

ASND

 

Ascendis Pharma A/S Ameri

$ 157.54

 
-$1.86 | -1.17%
 
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 158.20
 
 
MKT CAP
$ 9.09B
 
High
$ 161.00
 
 
VOL
$ 310.04K
 
Low
$ 156.79
 
 
AVG VOL
$ 0.47M
 
 
 

ASND Analysis

Ascendis Pharma A/S Ameri (ASND) still has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

Chart

 
 

131.23

91.41

93.57

113.35

 
 
1month
3month
6month
1year
 
Total Return
ASND
vs.
S&P500
 

 
1-week Return
+0.50%
 
+1.89%
 
 
5-week Return
+19.33%
 
+4.75%
 
 
10-week Return
+42.97%
 
+9.17%
 
 
 

ASND Analysts Opinion

Overall standing by considering key factors, reflecting analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.00
 
 

Activity

×
 

Activity

4.00
 
 

Future

×
 

Future

4.00
 

ASND Future Sentiment

 Earnings are forecast to grow

 
 

ASND Analysts Opinion

ASND Analysts opinion is negative and it remained unchanged from the past 3 months

 

ASND Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
100%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
0%
100%
 
On Track
On Track
On Track
 

ASND Street Opinion 

ASND Street view is extremely ish and have positive views on the near-term outlook

 
ASND Performance Sentiment
Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
100%
0%
Positive
Negative
8 out of 8
events present
0 out of 8
events present
 

 
Highlights
Last Modify
Price
% Change

 
Investors Activity
2 Weeks Ago
139.29
-1.10%
 
New Product
2 Weeks Ago
143.14
+2.41%
 
New Product
3 Weeks Ago
129.93
+0.57%
 
Agreements
2 Month Ago
138.24
+6.57%
 
Investors Activity
2 Month Ago
127.36
+0.20%
 
 
ASND Latest News Feed

ascendis pharma to participate in the oppenheimer 34th annual healthcare life sciences conference. copenhagen denmark feb. 07 2024 (globe newswire) -- ascendis pharma a/s (nasdaq: asnd) today announced that company executives will participate in the opp

Wed Feb 7, 2024

Activity

hypoparathyroidism market is expected to exhibit impressive growth by 2032 assesses delveinsight | leading companies developing therapies - ascendis pharma amolyt pharma bridgebio calcilytix therapeutics. the hypoparathyroidism market is expected to g

Mon Feb 5, 2024

Activity
Potential

$100 invested in ascendis pharma 5 years ago would be worth this much today. ascendis pharma (nasdaq:) has outperformed the market over the past 5 years by 3.24% on an annualized basis producing an average annual return of 15.86%. currently ascendis pharm

Fri Feb 2, 2024

Activity

ascendis pharma launches 2nd transcon™ product: yorvipath® now available in germany and austria for adults with chronic hypoparathyroidism. copenhagen denmark jan. 31 2024 (globe newswire) -- ascendis pharma a/s asnd today announced that yorvipath® (palop

Wed Jan 31, 2024

Activity

specialised therapeutics signs deal with ascendis for commercialization of 3 endocrinology therapies. (rttnews) - specialised therapeutics asia pte ltd an independent biopharmaceutical company said it signed an exclusive agreement with danish co

Mon Jan 8, 2024

Activity

ascendis pharma to participate in the 42nd annual j.p. morgan healthcare conference. copenhagen denmark dec. 28 2023 (globe newswire) -- ascendis pharma a/s (nasdaq:) today announced that jan mikkelsen president &. chief executive officer scott smi

Thu Dec 28, 2023

Activity

 
 
 
 
 

Score Tracker

 
 
 
Based on 8 events in the last 90 days from financial news and social media. Last updated Feb 26, 2024 23:13 Wall St. time
 
 

ASND Total Score

 
 
 
 
 
 
 
StocksRunner

Discover ASND Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of ASND. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ASND Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ASND Stock trends

ASND Stock performance

ASND Stock analysis

ASND investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker